Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer

Published:2020-03 Issue: Volume:141 Page:21-31
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Yoshimura Katsuhiro,Inoue Yusuke,Tsuchiya Kazuo,Karayama Masato^ORCID,Yamada Hidetaka,Iwashita Yuji,Kawase Akikazu,Tanahashi Masayuki,Ogawa Hiroshi,Inui Naoki^ORCID,Funai Kazuhito^ORCID,Shinmura Kazuya,Niwa Hiroshi,Suda Takafumi,Sugimura Haruhiko^ORCID

Funder

Japanese Ministry of Health, Labor and Welfare

the Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

National Cancer Center Research and Development Fund

Japanese Ministry of Health, Labor and Welfare, Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference67 articles.

1. Osimertinib in untreated EGFR-Mutated advanced non-small-cell lung cancer;Soria;N. Engl. J. Med.,2018

2. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial;Hida;Lancet,2017

3. Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion;Piotrowska;Cancer Discov.,2018

4. Pembrolizumab plus chemotherapy in metastatic non–Small-Cell lung Cancer;Gandhi;N. Engl. J. Med.,2018

5. EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer;Dong;Oncoimmunology,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer;CLIN LUNG CANCER;2024

2. Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer;Clinical Lung Cancer;2024-09

3. Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment;International Journal of Molecular Sciences;2024-08-22

4. Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis;CHINESE J CANCER RES;2024

5. MET Oncogene Targeting for Cancer Immunotherapy;International Journal of Molecular Sciences;2024-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3